Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about apoe2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
graph TD
apoe2["apoe2"]
APOE3(["APOE3"])
apoe2 -->|"activates"| APOE3
APOE4(["APOE4"])
apoe2 -->|"activates"| APOE4
APOE(["APOE"])
apoe2 -->|"activates"| APOE
AMYLOID(["AMYLOID"])
apoe2 -->|"activates"| AMYLOID
AMYLOID__["AMYLOID-beta"]
apoe2 -->|"activates"| AMYLOID__
Neurodegeneration{"Neurodegeneration"}
apoe2 -.->|"inhibits"| Neurodegeneration
Neuroinflammation["Neuroinflammation"]
Neuroinflammation -.->|"inhibits"| apoe2
style apoe2 fill:#1a3a4a,stroke:#ef5350,stroke-width:3px,color:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:APOE2 | data_in | dataset_row | 0.00 |
| Aβ-mediated Neurodegeneration | protects_against | process | 0.92 |
| Ferroptosis | protects_against | process | 0.90 |
| Remyelination | associated_with | process | 0.90 |
| amyloid deposition | reduces | process | 0.90 |
| LDLR binding | impairs | process | 0.90 |
| Ldlr Binding | associated_with | process | 0.90 |
| Alzheimer's disease | decreases_risk | disease | 0.90 |
| Cardiovascular Disease | risk_factor_for | disease | 0.85 |
| Alzheimer'S Disease | protects_against | disease | 0.85 |
| Neurodegeneration | protects_against | disease | 0.85 |
| Alzheimer's Disease | protects_against | disease | 0.85 |
| Endolysosomal Dysfunction | associated_with | phenotype | 0.85 |
| Microglial Function | associated_with | phenotype | 0.85 |
| AMYLOID-BETA | modulates | protein | 0.85 |
| ferroptosis | inhibits | pathway | 0.80 |
| Tau-Mediated Neurodegeneration | protects_against | process | 0.80 |
| LDLR | binds_weakly | protein | 0.80 |
| neurons | associated_with | cell_type | 0.80 |
| ferroptosis | inhibits | pathway | 0.80 |
| ABCA7 | interacts_with | gene | 0.80 |
| APOE4 | protects_against | gene | 0.75 |
| APOE4 | associated_with | gene | 0.70 |
| APOE3 | associated_with | gene | 0.70 |
| ApoE4 | modulates | protein | 0.70 |
| endolysosomal function | associated_with | pathway | 0.70 |
| oxidized unsaturated lipids | targets | compound | 0.70 |
| neuroprotection | causes | phenotype | 0.70 |
| amyloid accumulation | protective_against | mechanism | 0.70 |
| APOE4 | targets | gene | 0.65 |
| BDNF | targets | gene | 0.65 |
| LDLR | interacts_with | gene | 0.65 |
| NEURON | activates | cell_type | 0.65 |
| OLIGODENDROCYTE | activates | cell_type | 0.65 |
| OLIGODENDROCYTES | activates | cell_type | 0.65 |
| APOE3 | protects_against | gene | 0.65 |
| NEURONS | activates | cell_type | 0.65 |
| NEURONS | associated_with | cell_type | 0.65 |
| NEURODEGENERATION | interacts_with | disease | 0.65 |
| APOE3 | targets | gene | 0.65 |
| NEURON | associated_with | cell_type | 0.65 |
| APOE3 | upregulates | entity | 0.60 |
| APOE3 | activates | entity | 0.60 |
| APOE4 | expressed_in | gene | 0.60 |
| BDNF | implicated_in | gene | 0.60 |
| lipid metabolism | participates_in | pathway | 0.60 |
| APOE4 | regulates | gene | 0.60 |
| APOE4 | upregulates | entity | 0.60 |
| APOE4 | activates | entity | 0.60 |
| APOE3 | interacts_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:APOE2 | data_in | dataset_row | 0.00 |
| 37645718 | exerts cell non-autonomous effect on | paper | 0.90 |
| 39056789 | lowers | paper | 0.90 |
| APOE | associated_with | gene | 0.65 |
| APOE | protects_against | gene | 0.65 |
| APOE | targets | gene | 0.65 |
| APOE | inhibits | gene | 0.65 |
| APOE | interacts_with | gene | 0.65 |
| APOE | activates | entity | 0.60 |
| APOE | expressed_in | gene | 0.60 |
| APOE | regulates | gene | 0.60 |
| Neuroinflammation | inhibits | process | 0.50 |
| ABCA7 | interacts_with | gene | 0.20 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| AAV-Mediated APOE2/APOE3 Gene Delivery to Convert APOE Genot | 0.700 | neurodegeneration | APOE4 targeting in neurodegeneration |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-02 | 4 hypotheses Top: 0.720
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning apoe2 in their description or question text
No additional research found